Tag: AbbVie

April 20, 2022 Off

AbbVie’s Crohn’s Disease Drug to Treat Patients in UK

By Author

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for AbbVie’s risankizumab for treatment of adults and adolescents (16-17 years) with Crohn’s Disease (CD) who have had an inadequate response to, lost response to or were intolerant or contraindicated to tumour necrosis factor-alpha (TNFα) antagonist therapies, vedolizumab and ustekinumab.

April 4, 2022 Off

AbbVie and We Are Pioneer Group Launch Golden Ticket Programme to Help UK Life Science Start-ups Accelerate the Delivery of Life-Changing Innovations to Patients

By Dino Mustafić

AbbVie, the global research-driven biopharmaceutical company and We Are Pioneer Group (WAPG), Europe’s largest ecosystem provider for science and innovation businesses, to support the thriving UK life sciences start-up community, has launched a programme designed to help early-stage life science companies commercialise drug discovery and gain access to crucial research space.

October 14, 2019 Off

Abbvie buys Allergan for $63B

By Dino Mustafić

Allergan’s shareholders have voted to approve to be bought by AbbVie Inc for approximately $63 billion, as more than 99 percent of the votes cast were in favor of the transaction, representing about 69% of the shares outstanding and eligible to be voted at each of the Allergan shareholder meetings held on October 14, 2019 in Dublin, Ireland.